Technical Analysis for NTRA - Natera, Inc.

Grade Last Price % Change Price Change
grade A 22.54 -1.10% -0.25
NTRA closed down 1.1 percent on Monday, May 20, 2019, on 47 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical NTRA trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Stochastic Sell Signal Bearish -1.10%
Slingshot Bullish Bullish Swing Setup -1.10%
Upper Bollinger Band Walk Strength -1.10%
Outside Day Range Expansion -1.10%

Older signals for NTRA ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Natera, Inc., a genetic testing company, develops and commercializes non-invasive methods for analyzing deoxyribonucleic acid (DNA) in the United States and Europe. The company primarily offers Panorama, a non-invasive prenatal test for fetal chromosomal abnormalities; Horizon test; and pre-implantation genetic screening and pre-implantation genetic diagnosis tests under the Spectrum brand to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization. It also provides products of conception testing under the Anora brand to analyze fetal chromosomes to understand the cause of miscarriage; non-invasive paternity testing products to determine paternity by analyzing the fragments of fetal DNA in a pregnant mother's blood and a blood sample from the alleged father; and high throughput carrier screening to determine the risk of passing severe genetic diseases on to offspring. Natera sells its tests directly and partner with other clinical laboratories to distribute its tests. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is headquartered in San Carlos, California.
Medicine Clinical Medicine Medical Genetics Medical Tests Applied Genetics DNA Genetic Testing DNA Paternity Testing In Vitro Fertilization
Is NTRA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 29.62
52 Week Low 11.08
Average Volume 777,555
200-Day Moving Average 19.2692
50-Day Moving Average 19.8992
20-Day Moving Average 20.189
10-Day Moving Average 21.168
Average True Range 1.2222
ADX 24.87
+DI 30.9986
-DI 13.5316
Chandelier Exit (Long, 3 ATRs ) 19.9334
Chandelier Exit (Short, 3 ATRs ) 20.9966
Upper Bollinger Band 23.6843
Lower Bollinger Band 16.6937
Percent B (%b) 0.84
BandWidth 34.625786
MACD Line 0.9069
MACD Signal Line 0.5394
MACD Histogram 0.3675
Fundamentals Value
Market Cap 1.2 Billion
Num Shares 53.2 Million
EPS -2.43
Price-to-Earnings (P/E) Ratio -9.28
Price-to-Sales 2.91
Price-to-Book 11.62
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.43
Resistance 3 (R3) 23.46 23.21 23.28
Resistance 2 (R2) 23.21 22.98 23.19 23.23
Resistance 1 (R1) 22.87 22.84 23.04 22.84 23.18
Pivot Point 22.62 22.62 22.70 22.60 22.62
Support 1 (S1) 22.28 22.39 22.45 22.25 21.90
Support 2 (S2) 22.03 22.25 22.01 21.85
Support 3 (S3) 21.69 22.03 21.80
Support 4 (S4) 21.66